Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: Synthesis, SAR analysis, and biological activity
Authors:
- 1 August 2008
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 16 (15) , 7127-7132
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: Design, synthesis, and biological evaluationBioorganic & Medicinal Chemistry Letters, 2007
- Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analoguesBioorganic & Medicinal Chemistry, 2007
- Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expressionJournal of Cancer Research and Clinical Oncology, 2005
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- Flavopiridol, a Novel Cyclin-Dependent Kinase Inhibitor, in Clinical DevelopmentAnnals of Pharmacotherapy, 2002
- Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory moleculesEuropean Journal of Pharmacology, 2001
- Small molecule modulators of cyclin-dependent kinases for cancer therapyOncogene, 2000
- Thio- and Oxoflavopiridols, Cyclin-Dependent Kinase 1-Selective Inhibitors: Synthesis and Biological EffectsJournal of Medicinal Chemistry, 2000
- Structure–activity relationship studies of flavopiridol analoguesBioorganic & Medicinal Chemistry Letters, 2000
- Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.Proceedings of the National Academy of Sciences, 1996